

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein heterotrimerization (GO:0070208) | 7.30461648 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.60544009 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 6.25364580 |
| 4 | short-chain fatty acid metabolic process (GO:0046459) | 5.74256939 |
| 5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.46955373 |
| 6 | blood vessel maturation (GO:0001955) | 5.40429791 |
| 7 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 5.21002784 |
| 8 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.12789791 |
| 9 | hyperosmotic salinity response (GO:0042538) | 5.08763120 |
| 10 | aggressive behavior (GO:0002118) | 5.08505103 |
| 11 | definitive hemopoiesis (GO:0060216) | 5.06248692 |
| 12 | regulation of sequestering of triglyceride (GO:0010889) | 5.04178024 |
| 13 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.99346395 |
| 14 | endothelium development (GO:0003158) | 4.85311561 |
| 15 | * collagen fibril organization (GO:0030199) | 4.79216290 |
| 16 | regulation of mast cell degranulation (GO:0043304) | 4.76761435 |
| 17 | positive regulation of fatty acid oxidation (GO:0046321) | 4.75123391 |
| 18 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.74905207 |
| 19 | triglyceride catabolic process (GO:0019433) | 4.60558977 |
| 20 | regulation of female receptivity (GO:0045924) | 4.59383435 |
| 21 | positive regulation of mast cell degranulation (GO:0043306) | 4.51914798 |
| 22 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.51914798 |
| 23 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.36227170 |
| 24 | fatty acid transmembrane transport (GO:1902001) | 4.26925131 |
| 25 | neutral lipid catabolic process (GO:0046461) | 4.22424333 |
| 26 | acylglycerol catabolic process (GO:0046464) | 4.22424333 |
| 27 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.22274665 |
| 28 | white fat cell differentiation (GO:0050872) | 4.12742468 |
| 29 | female mating behavior (GO:0060180) | 4.09302037 |
| 30 | regulation of penile erection (GO:0060405) | 4.03708552 |
| 31 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.97585836 |
| 32 | * collagen metabolic process (GO:0032963) | 3.97538227 |
| 33 | carnitine shuttle (GO:0006853) | 3.97319816 |
| 34 | brown fat cell differentiation (GO:0050873) | 3.95932087 |
| 35 | biotin metabolic process (GO:0006768) | 3.89937847 |
| 36 | regulation of cholesterol storage (GO:0010885) | 3.89469076 |
| 37 | * multicellular organismal macromolecule metabolic process (GO:0044259) | 3.88963811 |
| 38 | valine metabolic process (GO:0006573) | 3.85812506 |
| 39 | * collagen catabolic process (GO:0030574) | 3.84351515 |
| 40 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79858113 |
| 41 | seminiferous tubule development (GO:0072520) | 3.79822687 |
| 42 | regulation of fatty acid oxidation (GO:0046320) | 3.78440407 |
| 43 | basement membrane organization (GO:0071711) | 3.76831314 |
| 44 | * multicellular organismal metabolic process (GO:0044236) | 3.75484073 |
| 45 | extracellular fibril organization (GO:0043206) | 3.74534244 |
| 46 | lipid particle organization (GO:0034389) | 3.72835053 |
| 47 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.65789604 |
| 48 | endodermal cell differentiation (GO:0035987) | 3.65172051 |
| 49 | adenosine receptor signaling pathway (GO:0001973) | 3.65022813 |
| 50 | skin morphogenesis (GO:0043589) | 3.63796533 |
| 51 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.61932318 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.61368110 |
| 53 | dermatan sulfate metabolic process (GO:0030205) | 3.57010819 |
| 54 | * multicellular organismal catabolic process (GO:0044243) | 3.54957136 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.54102081 |
| 56 | endocardial cushion development (GO:0003197) | 3.49836146 |
| 57 | fatty acid beta-oxidation (GO:0006635) | 3.49219444 |
| 58 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.48994447 |
| 59 | ethanol oxidation (GO:0006069) | 3.48656683 |
| 60 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.46188448 |
| 61 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.45203160 |
| 62 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.44919980 |
| 63 | positive regulation of lipid catabolic process (GO:0050996) | 3.43513122 |
| 64 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.39968223 |
| 65 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.38421824 |
| 66 | thrombin receptor signaling pathway (GO:0070493) | 3.35846122 |
| 67 | cellular response to vitamin (GO:0071295) | 3.34789781 |
| 68 | deoxyribonucleotide catabolic process (GO:0009264) | 3.32968413 |
| 69 | triglyceride biosynthetic process (GO:0019432) | 3.31980522 |
| 70 | granulocyte differentiation (GO:0030851) | 3.31496015 |
| 71 | positive regulation of leukocyte degranulation (GO:0043302) | 3.29782419 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 3.29739070 |
| 73 | deoxyribose phosphate catabolic process (GO:0046386) | 3.28838703 |
| 74 | fibril organization (GO:0097435) | 3.28546527 |
| 75 | UV protection (GO:0009650) | 3.26013722 |
| 76 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.24523953 |
| 77 | acylglycerol biosynthetic process (GO:0046463) | 3.24043259 |
| 78 | neutral lipid biosynthetic process (GO:0046460) | 3.24043259 |
| 79 | acetyl-CoA metabolic process (GO:0006084) | 3.21160511 |
| 80 | positive regulation of mast cell activation (GO:0033005) | 3.20188507 |
| 81 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.19633912 |
| 82 | * extracellular matrix disassembly (GO:0022617) | 3.19160200 |
| 83 | relaxation of smooth muscle (GO:0044557) | 3.16497070 |
| 84 | ovulation from ovarian follicle (GO:0001542) | 3.16136878 |
| 85 | apoptotic cell clearance (GO:0043277) | 3.15242804 |
| 86 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.14883696 |
| 87 | negative regulation of macrophage differentiation (GO:0045650) | 3.13785767 |
| 88 | dermatan sulfate biosynthetic process (GO:0030208) | 3.13738098 |
| 89 | complement activation, alternative pathway (GO:0006957) | 3.13674944 |
| 90 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.13217725 |
| 91 | epoxygenase P450 pathway (GO:0019373) | 3.12921757 |
| 92 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.12397662 |
| 93 | prostanoid biosynthetic process (GO:0046457) | 3.11129694 |
| 94 | prostaglandin biosynthetic process (GO:0001516) | 3.11129694 |
| 95 | fatty acid oxidation (GO:0019395) | 3.10136829 |
| 96 | glomerular filtration (GO:0003094) | 3.09666240 |
| 97 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.09422844 |
| 98 | bone trabecula formation (GO:0060346) | 3.08490399 |
| 99 | triglyceride metabolic process (GO:0006641) | 3.05362798 |
| 100 | thioester biosynthetic process (GO:0035384) | 3.04125706 |
| 101 | acyl-CoA biosynthetic process (GO:0071616) | 3.04125706 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.03599387 |
| 103 | lipid oxidation (GO:0034440) | 3.03419202 |
| 104 | regulation of mast cell activation (GO:0033003) | 3.03022487 |
| 105 | carnitine transmembrane transport (GO:1902603) | 3.02739742 |
| 106 | platelet aggregation (GO:0070527) | 3.02571156 |
| 107 | fatty acid catabolic process (GO:0009062) | 3.00248211 |
| 108 | purinergic receptor signaling pathway (GO:0035587) | 2.98475625 |
| 109 | pinocytosis (GO:0006907) | 2.94726184 |
| 110 | cellular hyperosmotic response (GO:0071474) | 2.93582275 |
| 111 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.92101196 |
| 112 | acylglycerol metabolic process (GO:0006639) | 2.91883237 |
| 113 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.90872105 |
| 114 | regulation of erythrocyte differentiation (GO:0045646) | 2.90575939 |
| 115 | grooming behavior (GO:0007625) | 2.89932699 |
| 116 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.89917178 |
| 117 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.89608285 |
| 118 | glycerolipid catabolic process (GO:0046503) | 2.87229430 |
| 119 | neutral lipid metabolic process (GO:0006638) | 2.86707583 |
| 120 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.86631333 |
| 121 | ethanol metabolic process (GO:0006067) | 2.86487552 |
| 122 | mature B cell differentiation involved in immune response (GO:0002313) | 2.85684257 |
| 123 | renal filtration (GO:0097205) | 2.85432032 |
| 124 | negative regulation of fatty acid transport (GO:2000192) | 2.84545459 |
| 125 | regulation of triglyceride catabolic process (GO:0010896) | 2.84432707 |
| 126 | prostaglandin metabolic process (GO:0006693) | 2.83912596 |
| 127 | prostanoid metabolic process (GO:0006692) | 2.83912596 |
| 128 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.83480830 |
| 129 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.83184126 |
| 130 | cyclooxygenase pathway (GO:0019371) | 2.82258493 |
| 131 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.81494789 |
| 132 | positive regulation of glycogen metabolic process (GO:0070875) | 2.81017658 |
| 133 | growth hormone receptor signaling pathway (GO:0060396) | 2.80707993 |
| 134 | negative regulation of protein autophosphorylation (GO:0031953) | 2.79850624 |
| 135 | L-serine transport (GO:0015825) | 2.79842167 |
| 136 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.79809579 |
| 137 | hemoglobin metabolic process (GO:0020027) | 2.79117675 |
| 138 | fatty acid homeostasis (GO:0055089) | 2.79026931 |
| 139 | regulation of transmission of nerve impulse (GO:0051969) | 2.77358347 |
| 140 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.76737521 |
| 141 | maternal behavior (GO:0042711) | 2.76429586 |
| 142 | amino-acid betaine transport (GO:0015838) | 2.76353283 |
| 143 | carnitine transport (GO:0015879) | 2.76353283 |
| 144 | positive regulation of lipid storage (GO:0010884) | 2.76350283 |
| 145 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.76142443 |
| 146 | glial cell migration (GO:0008347) | 2.76016877 |
| 147 | extracellular matrix assembly (GO:0085029) | 2.74783602 |
| 148 | branched-chain amino acid metabolic process (GO:0009081) | 2.74346187 |
| 149 | positive regulation of glucose import (GO:0046326) | 2.74289315 |
| 150 | sulfur amino acid catabolic process (GO:0000098) | 2.73735055 |
| 151 | blood circulation (GO:0008015) | 2.73530757 |
| 152 | lipopolysaccharide metabolic process (GO:0008653) | 2.73208742 |
| 153 | positive regulation of macrophage cytokine production (GO:0060907) | 2.72576578 |
| 154 | regulation of complement activation (GO:0030449) | 2.72267142 |
| 155 | regulation of regulated secretory pathway (GO:1903305) | 2.71693734 |
| 156 | acylglycerol homeostasis (GO:0055090) | 2.70908046 |
| 157 | triglyceride homeostasis (GO:0070328) | 2.70908046 |
| 158 | regulation of plasminogen activation (GO:0010755) | 2.70444420 |
| 159 | facial nerve structural organization (GO:0021612) | 2.69471741 |
| 160 | negative regulation of granulocyte differentiation (GO:0030853) | 2.68197462 |
| 161 | cellular response to growth hormone stimulus (GO:0071378) | 2.67948553 |
| 162 | negative regulation of cartilage development (GO:0061037) | 2.67814957 |
| 163 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.67532931 |
| 164 | response to dietary excess (GO:0002021) | 2.67429256 |
| 165 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.65955022 |
| 166 | phagocytosis, engulfment (GO:0006911) | 2.65266986 |
| 167 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.65024683 |
| 168 | protein kinase C signaling (GO:0070528) | 2.64134075 |
| 169 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.63047894 |
| 170 | regulation of protein activation cascade (GO:2000257) | 2.63012668 |
| 171 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.62761820 |
| 172 | branched-chain amino acid catabolic process (GO:0009083) | 2.61965371 |
| 173 | glomerular basement membrane development (GO:0032836) | 2.61170991 |
| 174 | response to muramyl dipeptide (GO:0032495) | 2.60236331 |
| 175 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.59883919 |
| 176 | negative regulation of biomineral tissue development (GO:0070168) | 2.58979702 |
| 177 | keratan sulfate catabolic process (GO:0042340) | 2.58136483 |
| 178 | interkinetic nuclear migration (GO:0022027) | 2.57601610 |
| 179 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.56542730 |
| 180 | membrane invagination (GO:0010324) | 2.56067548 |
| 181 | defense response to protozoan (GO:0042832) | 2.55144914 |
| 182 | response to misfolded protein (GO:0051788) | 2.55015658 |
| 183 | negative regulation of bone mineralization (GO:0030502) | 2.49897135 |
| 184 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.47481930 |
| 185 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.45818616 |
| 186 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.45455195 |
| 187 | stress fiber assembly (GO:0043149) | 2.44683390 |
| 188 | positive regulation of regulated secretory pathway (GO:1903307) | 2.43401829 |
| 189 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.42320890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.13792490 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.68091840 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.82740524 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.37047012 |
| 5 | * CLOCK_20551151_ChIP-Seq_293T_Human | 3.95483217 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.90126832 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.89464090 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.75522243 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.73188729 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.53821398 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.19441565 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.16242610 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.93364382 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.82949056 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.73043846 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.68985704 |
| 17 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51216039 |
| 18 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.42998471 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.32998162 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28128325 |
| 21 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.27996177 |
| 22 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.24734487 |
| 23 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.22151265 |
| 24 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21508555 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10364137 |
| 26 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.95277170 |
| 27 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.94843315 |
| 28 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.81991254 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81674213 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80993124 |
| 31 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.80202485 |
| 32 | CJUN_26792858_Chip-Seq_BT549_Human | 1.80063875 |
| 33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.75660498 |
| 34 | P68_20966046_ChIP-Seq_HELA_Human | 1.73200482 |
| 35 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.72730694 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.67998941 |
| 37 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.67946315 |
| 38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.67413722 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.65783182 |
| 40 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59240007 |
| 41 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.58645293 |
| 42 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.58166943 |
| 43 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.54305817 |
| 44 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51550303 |
| 45 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.50765696 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.47550519 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.47429206 |
| 48 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.46464444 |
| 49 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.46464444 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45933280 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45789559 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45598806 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42217868 |
| 54 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40047589 |
| 55 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38693581 |
| 56 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.38237434 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.36989731 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36797092 |
| 59 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.34990723 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33293705 |
| 61 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.32360887 |
| 62 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.32264273 |
| 63 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.31656209 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30286560 |
| 65 | P300_27268052_Chip-Seq_Bcells_Human | 1.29802987 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28075711 |
| 67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27504926 |
| 68 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.27099100 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26581219 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23953985 |
| 71 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.23893780 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23126980 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22531499 |
| 74 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21963071 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21447835 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20552263 |
| 77 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20529369 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20240799 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19370148 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19370148 |
| 81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17278727 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16983374 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16891442 |
| 84 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16368150 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16195097 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15701524 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15043629 |
| 88 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.14992754 |
| 89 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14899765 |
| 90 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.14305831 |
| 91 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.14065248 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13392513 |
| 93 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.11592067 |
| 94 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09808112 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08824880 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08053812 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07743779 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05953714 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05925494 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05473355 |
| 101 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05245390 |
| 102 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05074103 |
| 103 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04999504 |
| 104 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.04605151 |
| 105 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04325887 |
| 106 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04063706 |
| 107 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03934983 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03657989 |
| 109 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03475537 |
| 110 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02575048 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02474137 |
| 112 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01950952 |
| 113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01463653 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00977192 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00057379 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99573935 |
| 117 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98614794 |
| 118 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98614794 |
| 119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97310599 |
| 120 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.96320297 |
| 121 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.95033001 |
| 122 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.94976811 |
| 123 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94694686 |
| 124 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94677688 |
| 125 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94523023 |
| 126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94110986 |
| 127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93628095 |
| 128 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92965706 |
| 129 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92921213 |
| 130 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92647456 |
| 131 | MAF_26560356_Chip-Seq_TH1_Human | 0.91869388 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91641877 |
| 133 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91330967 |
| 134 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90721389 |
| 135 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90294717 |
| 136 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.89892128 |
| 137 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89551872 |
| 138 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.89154897 |
| 139 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.88783329 |
| 140 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88007100 |
| 141 | MAF_26560356_Chip-Seq_TH2_Human | 0.87985157 |
| 142 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87921672 |
| 143 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87372015 |
| 144 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87324834 |
| 145 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.87324834 |
| 146 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86974911 |
| 147 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86517871 |
| 148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86385547 |
| 149 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85759538 |
| 150 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85261505 |
| 151 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83513794 |
| 152 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.83155778 |
| 153 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82335869 |
| 154 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.81926154 |
| 155 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81458888 |
| 156 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81193825 |
| 157 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.80492733 |
| 158 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.80421123 |
| 159 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80169189 |
| 160 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79702452 |
| 161 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79075199 |
| 162 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.77847764 |
| 163 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.77494895 |
| 164 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.77130335 |
| 165 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.77106844 |
| 166 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.76016326 |
| 167 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75959982 |
| 168 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75598663 |
| 169 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75535917 |
| 170 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75424891 |
| 171 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.73247687 |
| 172 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.72654671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 8.28450793 |
| 2 | MP0005275_abnormal_skin_tensile | 5.44822021 |
| 3 | MP0005670_abnormal_white_adipose | 4.42571308 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.85204838 |
| 5 | MP0005503_abnormal_tendon_morphology | 3.57294901 |
| 6 | MP0000465_gastrointestinal_hemorrhage | 3.51289134 |
| 7 | MP0004272_abnormal_basement_membrane | 3.37871328 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 3.26391187 |
| 9 | MP0001545_abnormal_hematopoietic_system | 3.26391187 |
| 10 | MP0003279_aneurysm | 3.03152375 |
| 11 | MP0005666_abnormal_adipose_tissue | 3.02474164 |
| 12 | MP0004130_abnormal_muscle_cell | 2.67895748 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.58650578 |
| 14 | MP0009278_abnormal_bone_marrow | 2.57728792 |
| 15 | MP0000751_myopathy | 2.57682015 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.56597236 |
| 17 | MP0005375_adipose_tissue_phenotype | 2.48657470 |
| 18 | MP0002060_abnormal_skin_morphology | 2.28009379 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.25255443 |
| 20 | MP0001958_emphysema | 2.21075929 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.12861509 |
| 22 | MP0000003_abnormal_adipose_tissue | 2.04650458 |
| 23 | MP0008004_abnormal_stomach_pH | 1.85582696 |
| 24 | MP0002108_abnormal_muscle_morphology | 1.80196093 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.77248882 |
| 26 | MP0002971_abnormal_brown_adipose | 1.64795410 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.63089096 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.61639392 |
| 29 | MP0006054_spinal_hemorrhage | 1.58674044 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.58318372 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.58239760 |
| 32 | MP0009115_abnormal_fat_cell | 1.55444500 |
| 33 | MP0001661_extended_life_span | 1.52861189 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.52819495 |
| 35 | MP0005165_increased_susceptibility_to | 1.50522543 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.42867647 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.40104582 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.39613243 |
| 39 | MP0003045_fibrosis | 1.39573873 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.34049410 |
| 41 | MP0000230_abnormal_systemic_arterial | 1.33797615 |
| 42 | MP0005365_abnormal_bile_salt | 1.33253491 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.33037641 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.32552819 |
| 45 | MP0009379_abnormal_foot_pigmentation | 1.32331408 |
| 46 | MP0005334_abnormal_fat_pad | 1.28998200 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.28648401 |
| 48 | MP0001851_eye_inflammation | 1.27766784 |
| 49 | MP0003303_peritoneal_inflammation | 1.27542771 |
| 50 | MP0001243_abnormal_dermal_layer | 1.26344010 |
| 51 | MP0005508_abnormal_skeleton_morphology | 1.25253912 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.22341656 |
| 53 | MP0005360_urolithiasis | 1.18503429 |
| 54 | MP0004087_abnormal_muscle_fiber | 1.18254121 |
| 55 | MP0000749_muscle_degeneration | 1.17437467 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.17128655 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.16564509 |
| 58 | MP0003436_decreased_susceptibility_to | 1.16496427 |
| 59 | MP0009384_cardiac_valve_regurgitation | 1.14440923 |
| 60 | MP0002970_abnormal_white_adipose | 1.13697773 |
| 61 | MP0003091_abnormal_cell_migration | 1.10055504 |
| 62 | MP0005023_abnormal_wound_healing | 1.09709867 |
| 63 | MP0000759_abnormal_skeletal_muscle | 1.07588399 |
| 64 | MP0003075_altered_response_to | 1.07431912 |
| 65 | MP0002168_other_aberrant_phenotype | 1.07091038 |
| 66 | MP0000681_abnormal_thyroid_gland | 1.05746767 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.04964250 |
| 68 | MP0000733_abnormal_muscle_development | 1.03632308 |
| 69 | MP0002282_abnormal_trachea_morphology | 1.03392478 |
| 70 | MP0001542_abnormal_bone_strength | 1.00652994 |
| 71 | MP0003186_abnormal_redox_activity | 0.99558666 |
| 72 | MP0003959_abnormal_lean_body | 0.98551643 |
| 73 | MP0002132_abnormal_respiratory_system | 0.98030387 |
| 74 | MP0005646_abnormal_pituitary_gland | 0.96142874 |
| 75 | MP0008775_abnormal_heart_ventricle | 0.93592657 |
| 76 | MP0009697_abnormal_copulation | 0.92478812 |
| 77 | MP0002396_abnormal_hematopoietic_system | 0.92352501 |
| 78 | MP0002896_abnormal_bone_mineralization | 0.91790224 |
| 79 | MP0006138_congestive_heart_failure | 0.91511138 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.91357448 |
| 81 | MP0002006_tumorigenesis | 0.89349063 |
| 82 | MP0005330_cardiomyopathy | 0.89265295 |
| 83 | MP0002733_abnormal_thermal_nociception | 0.89233643 |
| 84 | MP0000609_abnormal_liver_physiology | 0.88845183 |
| 85 | MP0005164_abnormal_response_to | 0.88190219 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.87061136 |
| 87 | MP0003252_abnormal_bile_duct | 0.87025315 |
| 88 | MP0001881_abnormal_mammary_gland | 0.86514631 |
| 89 | MP0002735_abnormal_chemical_nociception | 0.85479550 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.85396144 |
| 91 | MP0000747_muscle_weakness | 0.84626078 |
| 92 | MP0005620_abnormal_muscle_contractility | 0.84393153 |
| 93 | MP0003385_abnormal_body_wall | 0.83228271 |
| 94 | MP0002653_abnormal_ependyma_morphology | 0.81218571 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.79943144 |
| 96 | MP0005451_abnormal_body_composition | 0.79549729 |
| 97 | MP0005369_muscle_phenotype | 0.78936124 |
| 98 | MP0001873_stomach_inflammation | 0.78883096 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.78291016 |
| 100 | MP0009763_increased_sensitivity_to | 0.77469671 |
| 101 | MP0005385_cardiovascular_system_phenoty | 0.77137292 |
| 102 | MP0001544_abnormal_cardiovascular_syste | 0.77137292 |
| 103 | MP0004808_abnormal_hematopoietic_stem | 0.76260296 |
| 104 | MP0005390_skeleton_phenotype | 0.75740663 |
| 105 | MP0002796_impaired_skin_barrier | 0.75239599 |
| 106 | MP0002254_reproductive_system_inflammat | 0.75233752 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.75196316 |
| 108 | MP0002269_muscular_atrophy | 0.74592641 |
| 109 | MP0008789_abnormal_olfactory_epithelium | 0.74059003 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.73954689 |
| 111 | MP0005448_abnormal_energy_balance | 0.73901500 |
| 112 | MP0000343_altered_response_to | 0.73120473 |
| 113 | MP0001835_abnormal_antigen_presentation | 0.72682369 |
| 114 | MP0004134_abnormal_chest_morphology | 0.72504001 |
| 115 | MP0000249_abnormal_blood_vessel | 0.71345123 |
| 116 | MP0001879_abnormal_lymphatic_vessel | 0.70200653 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.69916732 |
| 118 | MP0002106_abnormal_muscle_physiology | 0.68844286 |
| 119 | MP0004036_abnormal_muscle_relaxation | 0.68458250 |
| 120 | MP0004859_abnormal_synaptic_plasticity | 0.67811810 |
| 121 | MP0004084_abnormal_cardiac_muscle | 0.67498441 |
| 122 | MP0010630_abnormal_cardiac_muscle | 0.65707609 |
| 123 | MP0000163_abnormal_cartilage_morphology | 0.65665512 |
| 124 | MP0008874_decreased_physiological_sensi | 0.65486895 |
| 125 | MP0005171_absent_coat_pigmentation | 0.64902531 |
| 126 | MP0003690_abnormal_glial_cell | 0.64547281 |
| 127 | MP0010771_integument_phenotype | 0.64474227 |
| 128 | MP0010352_gastrointestinal_tract_polyps | 0.64328926 |
| 129 | MP0003724_increased_susceptibility_to | 0.63957031 |
| 130 | MP0001853_heart_inflammation | 0.63857558 |
| 131 | MP0002128_abnormal_blood_circulation | 0.63747039 |
| 132 | MP0002933_joint_inflammation | 0.63439471 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.63414072 |
| 134 | MP0005076_abnormal_cell_differentiation | 0.62627258 |
| 135 | MP0001533_abnormal_skeleton_physiology | 0.62295474 |
| 136 | MP0001299_abnormal_eye_distance/ | 0.62017930 |
| 137 | MP0004858_abnormal_nervous_system | 0.61790227 |
| 138 | MP0005410_abnormal_fertilization | 0.61660661 |
| 139 | MP0002398_abnormal_bone_marrow | 0.61599180 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.61532088 |
| 141 | MP0005025_abnormal_response_to | 0.61052451 |
| 142 | MP0005085_abnormal_gallbladder_physiolo | 0.60691364 |
| 143 | MP0005535_abnormal_body_temperature | 0.60285616 |
| 144 | MP0002419_abnormal_innate_immunity | 0.59807201 |
| 145 | MP0008569_lethality_at_weaning | 0.59554857 |
| 146 | MP0010368_abnormal_lymphatic_system | 0.59512751 |
| 147 | MP0003763_abnormal_thymus_physiology | 0.59286664 |
| 148 | MP0002115_abnormal_skeleton_extremities | 0.59278958 |
| 149 | MP0005452_abnormal_adipose_tissue | 0.59208246 |
| 150 | MP0005166_decreased_susceptibility_to | 0.59061806 |
| 151 | MP0001614_abnormal_blood_vessel | 0.59058303 |
| 152 | MP0003828_pulmonary_edema | 0.56723652 |
| 153 | MP0001756_abnormal_urination | 0.56634013 |
| 154 | MP0009250_abnormal_appendicular_skeleto | 0.56519513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 7.02812348 |
| 2 | Premature rupture of membranes (HP:0001788) | 6.90247480 |
| 3 | Ankle contracture (HP:0006466) | 6.05476240 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 5.44026264 |
| 5 | Increased connective tissue (HP:0009025) | 5.33035245 |
| 6 | Aortic dissection (HP:0002647) | 4.83342556 |
| 7 | Follicular hyperkeratosis (HP:0007502) | 4.74504744 |
| 8 | Broad metatarsal (HP:0001783) | 4.69416455 |
| 9 | Cerebral aneurysm (HP:0004944) | 4.45679048 |
| 10 | Exercise-induced myalgia (HP:0003738) | 4.38153347 |
| 11 | Soft skin (HP:0000977) | 4.35583995 |
| 12 | Atrophic scars (HP:0001075) | 4.31366486 |
| 13 | Slender build (HP:0001533) | 4.24841658 |
| 14 | Peritonitis (HP:0002586) | 4.14818957 |
| 15 | Spinal rigidity (HP:0003306) | 4.04838713 |
| 16 | Increased variability in muscle fiber diameter (HP:0003557) | 4.04106231 |
| 17 | Abnormal pupillary function (HP:0007686) | 4.03243732 |
| 18 | Fragile skin (HP:0001030) | 3.97713421 |
| 19 | Distal arthrogryposis (HP:0005684) | 3.68379408 |
| 20 | Shallow orbits (HP:0000586) | 3.66342395 |
| 21 | Dilatation of the ascending aorta (HP:0005111) | 3.63286205 |
| 22 | Mitral valve prolapse (HP:0001634) | 3.61115456 |
| 23 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.50948514 |
| 24 | Bladder diverticulum (HP:0000015) | 3.44916181 |
| 25 | Hypertensive crisis (HP:0100735) | 3.39214555 |
| 26 | Petechiae (HP:0000967) | 3.39007523 |
| 27 | Muscle fiber splitting (HP:0003555) | 3.38086769 |
| 28 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.35743956 |
| 29 | Aortic aneurysm (HP:0004942) | 3.32319700 |
| 30 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.28647269 |
| 31 | Acanthosis nigricans (HP:0000956) | 3.10464324 |
| 32 | Prolonged bleeding time (HP:0003010) | 3.09500274 |
| 33 | Areflexia of lower limbs (HP:0002522) | 3.01083931 |
| 34 | Muscle stiffness (HP:0003552) | 2.99647251 |
| 35 | Episodic fever (HP:0001954) | 2.96421999 |
| 36 | Striae distensae (HP:0001065) | 2.90098400 |
| 37 | Genu recurvatum (HP:0002816) | 2.85501142 |
| 38 | Epistaxis (HP:0000421) | 2.77814841 |
| 39 | Blue sclerae (HP:0000592) | 2.76741581 |
| 40 | Oligomenorrhea (HP:0000876) | 2.75506777 |
| 41 | Purpura (HP:0000979) | 2.73963896 |
| 42 | Venous abnormality (HP:0002624) | 2.72928481 |
| 43 | Venous insufficiency (HP:0005293) | 2.71373987 |
| 44 | Neonatal short-limb short stature (HP:0008921) | 2.71238942 |
| 45 | Increased mean platelet volume (HP:0011877) | 2.70672186 |
| 46 | Difficulty running (HP:0009046) | 2.69055517 |
| 47 | Joint stiffness (HP:0001387) | 2.65619686 |
| 48 | Infantile muscular hypotonia (HP:0008947) | 2.64551402 |
| 49 | Hyperextensible skin (HP:0000974) | 2.63539489 |
| 50 | Ectopia lentis (HP:0001083) | 2.59966208 |
| 51 | Gingival bleeding (HP:0000225) | 2.58270095 |
| 52 | Visual hallucinations (HP:0002367) | 2.57106934 |
| 53 | Wormian bones (HP:0002645) | 2.56736488 |
| 54 | Thrombocytosis (HP:0001894) | 2.56528384 |
| 55 | Biconcave vertebral bodies (HP:0004586) | 2.50738095 |
| 56 | Abnormal platelet volume (HP:0011876) | 2.50429652 |
| 57 | Aneurysm (HP:0002617) | 2.48898747 |
| 58 | Round ear (HP:0100830) | 2.47409972 |
| 59 | Wrist flexion contracture (HP:0001239) | 2.47226512 |
| 60 | Abnormality of dentin (HP:0010299) | 2.47152788 |
| 61 | Cellulitis (HP:0100658) | 2.46473072 |
| 62 | Rhabdomyolysis (HP:0003201) | 2.45429707 |
| 63 | Hypertriglyceridemia (HP:0002155) | 2.43895727 |
| 64 | Increased muscle lipid content (HP:0009058) | 2.42288731 |
| 65 | Myocardial infarction (HP:0001658) | 2.41472201 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41234692 |
| 67 | Cervical subluxation (HP:0003308) | 2.38650456 |
| 68 | Osteolytic defects of the hand bones (HP:0009699) | 2.37226074 |
| 69 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.37226074 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.36146846 |
| 71 | Mitral stenosis (HP:0001718) | 2.35785897 |
| 72 | Generalized amyotrophy (HP:0003700) | 2.33878448 |
| 73 | Complement deficiency (HP:0004431) | 2.33105730 |
| 74 | Bone cyst (HP:0012062) | 2.31248917 |
| 75 | Xanthomatosis (HP:0000991) | 2.26090090 |
| 76 | Abnormal delivery (HP:0001787) | 2.25949169 |
| 77 | Redundant skin (HP:0001582) | 2.23483537 |
| 78 | Hyperthyroidism (HP:0000836) | 2.22360298 |
| 79 | Hyporeflexia of lower limbs (HP:0002600) | 2.22278689 |
| 80 | Joint laxity (HP:0001388) | 2.21463433 |
| 81 | Breech presentation (HP:0001623) | 2.21019737 |
| 82 | Hypoalphalipoproteinemia (HP:0003233) | 2.20315238 |
| 83 | Stomatitis (HP:0010280) | 2.19247276 |
| 84 | Alopecia of scalp (HP:0002293) | 2.18013657 |
| 85 | Elbow flexion contracture (HP:0002987) | 2.16916250 |
| 86 | Bowel diverticulosis (HP:0005222) | 2.16057074 |
| 87 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14447132 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.13391861 |
| 89 | Bruising susceptibility (HP:0000978) | 2.12981819 |
| 90 | Osteoarthritis (HP:0002758) | 2.11355772 |
| 91 | Vertebral compression fractures (HP:0002953) | 2.11129283 |
| 92 | Increased serum ferritin (HP:0003281) | 2.10641618 |
| 93 | Menorrhagia (HP:0000132) | 2.08867381 |
| 94 | Enlarged penis (HP:0000040) | 2.08106406 |
| 95 | Overgrowth (HP:0001548) | 2.06563807 |
| 96 | Renal Fanconi syndrome (HP:0001994) | 2.05330536 |
| 97 | Vascular tortuosity (HP:0004948) | 2.04405082 |
| 98 | Atelectasis (HP:0100750) | 2.03654915 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03318535 |
| 100 | Limb-girdle muscle weakness (HP:0003325) | 2.03255892 |
| 101 | Skin nodule (HP:0200036) | 2.03181702 |
| 102 | Easy fatigability (HP:0003388) | 2.02424345 |
| 103 | Hyperglycinuria (HP:0003108) | 2.00950790 |
| 104 | Abnormality of the tricuspid valve (HP:0001702) | 1.99536255 |
| 105 | Lipoatrophy (HP:0100578) | 1.98793822 |
| 106 | Turricephaly (HP:0000262) | 1.98029769 |
| 107 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96128537 |
| 108 | Right ventricular cardiomyopathy (HP:0011663) | 1.96024465 |
| 109 | Congenital hip dislocation (HP:0001374) | 1.94566434 |
| 110 | Autoimmune hemolytic anemia (HP:0001890) | 1.93729140 |
| 111 | Nonimmune hydrops fetalis (HP:0001790) | 1.92734075 |
| 112 | Focal motor seizures (HP:0011153) | 1.90818455 |
| 113 | Hemorrhage of the eye (HP:0011885) | 1.90681934 |
| 114 | Hypoventilation (HP:0002791) | 1.90124595 |
| 115 | J-shaped sella turcica (HP:0002680) | 1.88987600 |
| 116 | Aortic regurgitation (HP:0001659) | 1.88742590 |
| 117 | Ragged-red muscle fibers (HP:0003200) | 1.87556150 |
| 118 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87493041 |
| 119 | Mucopolysacchariduria (HP:0008155) | 1.87493041 |
| 120 | Hypoplasia of the iris (HP:0007676) | 1.86720682 |
| 121 | Abnormality of complement system (HP:0005339) | 1.86530062 |
| 122 | Hepatosplenomegaly (HP:0001433) | 1.86047883 |
| 123 | Difficulty climbing stairs (HP:0003551) | 1.84880317 |
| 124 | Myoglobinuria (HP:0002913) | 1.84002154 |
| 125 | Thin bony cortex (HP:0002753) | 1.83997000 |
| 126 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83890724 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83890724 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83890724 |
| 129 | Flexion contracture of toe (HP:0005830) | 1.81963937 |
| 130 | Joint contractures involving the joints of the feet (HP:0100492) | 1.81963937 |
| 131 | Back pain (HP:0003418) | 1.81593129 |
| 132 | Wide anterior fontanel (HP:0000260) | 1.80885136 |
| 133 | Pulmonary artery stenosis (HP:0004415) | 1.80857038 |
| 134 | Deep venous thrombosis (HP:0002625) | 1.80669105 |
| 135 | Spondylolisthesis (HP:0003302) | 1.79366851 |
| 136 | Thin skin (HP:0000963) | 1.78261284 |
| 137 | Dysostosis multiplex (HP:0000943) | 1.76952646 |
| 138 | Trismus (HP:0000211) | 1.75806525 |
| 139 | Pulmonary hypertension (HP:0002092) | 1.75701890 |
| 140 | Epidermoid cyst (HP:0200040) | 1.75646539 |
| 141 | Tibial bowing (HP:0002982) | 1.75476684 |
| 142 | Camptodactyly of toe (HP:0001836) | 1.74954744 |
| 143 | Lymphangioma (HP:0100764) | 1.74539158 |
| 144 | Hydroxyprolinuria (HP:0003080) | 1.74224233 |
| 145 | Abnormality of proline metabolism (HP:0010907) | 1.74224233 |
| 146 | Obstructive lung disease (HP:0006536) | 1.73779377 |
| 147 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.73599224 |
| 148 | Abnormality of the acetabulum (HP:0003170) | 1.72990477 |
| 149 | Ulnar bowing (HP:0003031) | 1.72571604 |
| 150 | Achilles tendon contracture (HP:0001771) | 1.70159549 |
| 151 | Abnormality of the Achilles tendon (HP:0005109) | 1.69898396 |
| 152 | Abnormality of the peritoneum (HP:0002585) | 1.69026785 |
| 153 | Hyperlipoproteinemia (HP:0010980) | 1.68285625 |
| 154 | Deviation of the hallux (HP:0010051) | 1.67592335 |
| 155 | Mitral regurgitation (HP:0001653) | 1.67483746 |
| 156 | Buphthalmos (HP:0000557) | 1.67024001 |
| 157 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.66816149 |
| 158 | Abnormality of glycine metabolism (HP:0010895) | 1.66816149 |
| 159 | Gingival overgrowth (HP:0000212) | 1.63561785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.34481639 |
| 2 | SIK1 | 4.25999467 |
| 3 | CAMK1D | 3.75850426 |
| 4 | ERN1 | 3.57302434 |
| 5 | PDGFRA | 3.41471934 |
| 6 | MAP3K11 | 3.38519352 |
| 7 | TTN | 3.25589417 |
| 8 | CAMK1G | 2.80543512 |
| 9 | DDR2 | 2.71303493 |
| 10 | VRK2 | 2.62395043 |
| 11 | RIPK1 | 2.40187721 |
| 12 | PIM2 | 2.35976357 |
| 13 | BCKDK | 2.34455838 |
| 14 | SCYL2 | 2.18528718 |
| 15 | PKN2 | 2.08371331 |
| 16 | KDR | 2.07194024 |
| 17 | TESK1 | 1.98741434 |
| 18 | TBK1 | 1.97096126 |
| 19 | MAP3K10 | 1.92298325 |
| 20 | TAOK2 | 1.91640640 |
| 21 | FGFR4 | 1.90582216 |
| 22 | NME2 | 1.86547895 |
| 23 | MAP3K1 | 1.83621015 |
| 24 | PRPF4B | 1.81487762 |
| 25 | FES | 1.81268289 |
| 26 | CCNB1 | 1.63831676 |
| 27 | LATS1 | 1.58646943 |
| 28 | MYLK | 1.58355168 |
| 29 | LATS2 | 1.56527269 |
| 30 | JAK3 | 1.51388563 |
| 31 | PBK | 1.48065757 |
| 32 | MST1R | 1.46647738 |
| 33 | PDK4 | 1.45501155 |
| 34 | PDK3 | 1.45501155 |
| 35 | MAP3K12 | 1.44824084 |
| 36 | EPHB2 | 1.40252450 |
| 37 | TESK2 | 1.40108502 |
| 38 | TGFBR2 | 1.37764966 |
| 39 | PAK2 | 1.37141436 |
| 40 | LMTK2 | 1.31890703 |
| 41 | BMX | 1.31691862 |
| 42 | FGFR2 | 1.29983356 |
| 43 | EPHB1 | 1.25691338 |
| 44 | PDGFRB | 1.23139817 |
| 45 | MAP2K1 | 1.23073931 |
| 46 | FER | 1.22233011 |
| 47 | FGFR3 | 1.21744812 |
| 48 | EPHA3 | 1.17032737 |
| 49 | MET | 1.15571109 |
| 50 | INSRR | 1.14664957 |
| 51 | FRK | 1.13077353 |
| 52 | MAP4K2 | 1.13002598 |
| 53 | PTK6 | 1.12602456 |
| 54 | PRKAA2 | 1.11306098 |
| 55 | PKN1 | 1.10942794 |
| 56 | DAPK1 | 1.02952965 |
| 57 | TEC | 1.01080371 |
| 58 | PIK3CA | 0.98953693 |
| 59 | LIMK1 | 0.97555888 |
| 60 | CAMK1 | 0.97248885 |
| 61 | MTOR | 0.96599348 |
| 62 | DMPK | 0.96422632 |
| 63 | JAK1 | 0.95217060 |
| 64 | GRK6 | 0.95137389 |
| 65 | PIK3CG | 0.92107165 |
| 66 | ZAP70 | 0.92010675 |
| 67 | MAP4K1 | 0.91727782 |
| 68 | CDK6 | 0.90692418 |
| 69 | OBSCN | 0.90602801 |
| 70 | KIT | 0.90498839 |
| 71 | GRK5 | 0.89891984 |
| 72 | RET | 0.89091470 |
| 73 | ICK | 0.87044376 |
| 74 | PDK2 | 0.86275793 |
| 75 | TRPM7 | 0.84438007 |
| 76 | PTK2B | 0.83487939 |
| 77 | SYK | 0.83120110 |
| 78 | ARAF | 0.80579776 |
| 79 | PTK2 | 0.80098717 |
| 80 | NEK9 | 0.79056927 |
| 81 | MOS | 0.78874431 |
| 82 | PRKD1 | 0.78551491 |
| 83 | TAOK3 | 0.78103878 |
| 84 | FGFR1 | 0.77123326 |
| 85 | TYK2 | 0.76125816 |
| 86 | DAPK2 | 0.75170035 |
| 87 | BTK | 0.75126311 |
| 88 | ILK | 0.75125989 |
| 89 | LRRK2 | 0.73635397 |
| 90 | TNK2 | 0.73507338 |
| 91 | CAMK2G | 0.72152575 |
| 92 | NTRK1 | 0.72002158 |
| 93 | MAP3K5 | 0.71292821 |
| 94 | ROCK1 | 0.69580974 |
| 95 | PHKG2 | 0.69419940 |
| 96 | PHKG1 | 0.69419940 |
| 97 | MAP2K6 | 0.68557483 |
| 98 | ABL2 | 0.67615932 |
| 99 | PAK3 | 0.67514801 |
| 100 | PRKCH | 0.66789010 |
| 101 | MAP3K7 | 0.62098442 |
| 102 | INSR | 0.61586720 |
| 103 | PRKAA1 | 0.60449029 |
| 104 | DYRK1B | 0.60195783 |
| 105 | IKBKB | 0.58201312 |
| 106 | GSK3A | 0.57281513 |
| 107 | MAPK3 | 0.56923141 |
| 108 | MAP2K4 | 0.56375605 |
| 109 | STK38 | 0.55988677 |
| 110 | FLT3 | 0.55372545 |
| 111 | STK3 | 0.55161447 |
| 112 | CAMK2B | 0.54967559 |
| 113 | TIE1 | 0.54636145 |
| 114 | MATK | 0.53979641 |
| 115 | CSK | 0.53247973 |
| 116 | MAP2K2 | 0.52967931 |
| 117 | MAP2K3 | 0.52711947 |
| 118 | ERBB4 | 0.51626059 |
| 119 | ITK | 0.51522322 |
| 120 | EEF2K | 0.50839568 |
| 121 | DAPK3 | 0.48783486 |
| 122 | PRKD2 | 0.48437315 |
| 123 | MAPK11 | 0.48408517 |
| 124 | CDK9 | 0.48147313 |
| 125 | MAPKAPK3 | 0.48146316 |
| 126 | GRK7 | 0.47766675 |
| 127 | PAK6 | 0.47667502 |
| 128 | MAP3K3 | 0.44920298 |
| 129 | RAF1 | 0.44833772 |
| 130 | CAMK2D | 0.44703967 |
| 131 | PRKD3 | 0.44260760 |
| 132 | MARK2 | 0.41263583 |
| 133 | PRKCD | 0.41155188 |
| 134 | MAP2K7 | 0.40926594 |
| 135 | JAK2 | 0.40749347 |
| 136 | SRC | 0.40552748 |
| 137 | PAK4 | 0.40224995 |
| 138 | PDPK1 | 0.40180521 |
| 139 | IRAK3 | 0.39768306 |
| 140 | CDC42BPA | 0.39072313 |
| 141 | IGF1R | 0.38486417 |
| 142 | PRKCQ | 0.36952236 |
| 143 | ROCK2 | 0.36633626 |
| 144 | MAPK12 | 0.35918735 |
| 145 | PRKCA | 0.35557019 |
| 146 | ABL1 | 0.32079597 |
| 147 | PRKACA | 0.31173480 |
| 148 | MAPK10 | 0.31101015 |
| 149 | CSF1R | 0.30963405 |
| 150 | PRKG2 | 0.30892242 |
| 151 | PRKACG | 0.30241780 |
| 152 | VRK1 | 0.30205130 |
| 153 | MAP3K6 | 0.27590626 |
| 154 | ADRBK1 | 0.27092287 |
| 155 | MAPK4 | 0.25159256 |
| 156 | EPHA2 | 0.23553602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.43323522 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.27290481 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.27028271 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.93163548 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.85939985 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.79174302 |
| 7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.69527645 |
| 8 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.63806483 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60625784 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55372069 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.34561586 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.27203804 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.10665898 |
| 14 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 2.00027059 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.97126373 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91504663 |
| 17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.80202375 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.77292927 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74619196 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73652919 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65038543 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62252107 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59403297 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58902100 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53898961 |
| 26 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.51317841 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48241487 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.47139614 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.46627891 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.46182944 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45796418 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.45724172 |
| 33 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.45161429 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.41951148 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39782308 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33767524 |
| 37 | Insulin resistance_Homo sapiens_hsa04931 | 1.33439795 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.32158540 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30635302 |
| 40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.28740965 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27927701 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.24461896 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23866670 |
| 44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.22141435 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.20458953 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18084517 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.17900263 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.15951997 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.14979751 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14933967 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.13599723 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.13079319 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 1.12739283 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07889734 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07180475 |
| 56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.03803376 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.02714443 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02377962 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01818169 |
| 60 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00779189 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00605802 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99788698 |
| 63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97145970 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95646316 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95555425 |
| 66 | Salivary secretion_Homo sapiens_hsa04970 | 0.94277557 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.92042298 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.91764310 |
| 69 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.91154339 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90512637 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86110301 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84454078 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84328919 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.84012976 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83430418 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82381864 |
| 77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80537902 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78243982 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76054833 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.73970134 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73370646 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71663189 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.71478800 |
| 84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.70839072 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.70015868 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68587370 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.67642852 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67576862 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66658291 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.63402246 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63031318 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62417979 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61537897 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60593540 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.59449445 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59017112 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55198782 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54404112 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53944372 |
| 100 | Tuberculosis_Homo sapiens_hsa05152 | 0.53778601 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.52711095 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.51535489 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.51233485 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51056015 |
| 105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50380598 |
| 106 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50315473 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.49658427 |
| 108 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49509419 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49503687 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48061225 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.47958593 |
| 112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47678237 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47287466 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46539032 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46142121 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45393227 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44784253 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44727100 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.44666515 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44324838 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44013696 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43832761 |
| 123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41416483 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40532986 |
| 125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39777248 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38877270 |
| 127 | Renin secretion_Homo sapiens_hsa04924 | 0.38433067 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38271950 |
| 129 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37828434 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37255991 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37242164 |
| 132 | Insulin secretion_Homo sapiens_hsa04911 | 0.37120534 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.36501780 |
| 134 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36061613 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35971062 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35939965 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35042001 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34387681 |
| 139 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33923479 |
| 140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.32630588 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32146380 |
| 142 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32091756 |
| 143 | Pathways in cancer_Homo sapiens_hsa05200 | 0.30978248 |
| 144 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.30952096 |
| 145 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30108900 |
| 146 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30067435 |
| 147 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.29843919 |
| 148 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29653899 |
| 149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28833401 |
| 150 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28227905 |
| 151 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28078045 |
| 152 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27946986 |
| 153 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.27234818 |

